Your browser doesn't support javascript.
loading
Comparison of Panitumumab-IRDye800CW and 5-Aminolevulinic Acid to Provide Optical Contrast in a Model of Glioblastoma Multiforme.
Napier, Tiara S; Udayakumar, Neha; Jani, Aditi H; Hartman, Yolanda E; Houson, Hailey A; Moore, Lindsay; Amm, Hope M; van den Berg, Nynke S; Sorace, Anna G; Warram, Jason M.
Afiliación
  • Napier TS; Graduate Biomedical Sciences, University of Alabama at Birmingham, Birmingham, Alabama.
  • Udayakumar N; School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
  • Jani AH; Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
  • Hartman YE; Department of Otolaryngology, University of Alabama at Birmingham, Birmingham, Alabama.
  • Houson HA; Department of Otolaryngology, University of Alabama at Birmingham, Birmingham, Alabama.
  • Moore L; Department of Otolaryngology, University of Alabama at Birmingham, Birmingham, Alabama.
  • Amm HM; Department of Oral and Maxillofacial Surgery, University of Alabama at Birmingham, Birmingham, Alabama.
  • van den Berg NS; Department of Otolaryngology, Stanford University Medical School, Stanford, California.
  • Sorace AG; Department of Radiology, University of Alabama at Birmingham, Birmingham, Alabama.
  • Warram JM; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama.
Mol Cancer Ther ; 19(9): 1922-1929, 2020 09.
Article en En | MEDLINE | ID: mdl-32606015

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fármacos Fotosensibilizantes / Glioblastoma / Imagen Óptica / Antineoplásicos Inmunológicos / Panitumumab / Ácido Aminolevulínico Límite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fármacos Fotosensibilizantes / Glioblastoma / Imagen Óptica / Antineoplásicos Inmunológicos / Panitumumab / Ácido Aminolevulínico Límite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos